Pradelli, L., & Ascierto, P. (2017). [Reply to Letter to the Editor in reference to " Clinical and economic evaluation of the introduction of the combinazion trametinib + dabrafenib in the management of advanced melanoma in the Italian market”]. Farmeconomia. Health Economics and Therapeutic Pathways, 18(1). https://doi.org/10.7175/fe.v18i1.1329